The Enterprise Value as of September 2024 (TTM) for Applied Therapeutics, Inc. (APLT) is 532.64M

According to Applied Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 532.64M. This represents a change of 32.22% compared to the average of 402.85M of the last 4 quarters.

Applied Therapeutics, Inc. (APLT) Historical Enterprise Value (quarterly & annually)

How has APLT Enterprise Value performed in the past?

The mean historical Enterprise Value of Applied Therapeutics, Inc. over the last ten years is 190.61M. The current 532.64M Enterprise Value has changed 27.84% with respect to the historical average. Over the past ten years (40 quarters), APLT's Enterprise Value was at its highest in in the June 2020 quarter at 701.77M. The Enterprise Value was at its lowest in in the June 2022 quarter at -29103406.37.

Applied Therapeutics, Inc. (APLT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Applied Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Applied Therapeutics, Inc. (APLT) Average Enterprise Value

How has APLT Enterprise Value performed in the past?

The current Enterprise Value of Applied Therapeutics, Inc. (APLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Applied Therapeutics, Inc. (APLT) Enterprise Value vs. Peers

How is APLT’s Enterprise Value compared to its peers?

Applied Therapeutics, Inc.’s Enterprise Value is greater than X4 Pharmaceuticals, Inc. (40.79M), greater than Galera Therapeutics, Inc. (-5475585.00), greater than Terns Pharmaceuticals, Inc. (458.36M), less than Day One Biopharmaceuticals, Inc. (1.01B), greater than HOOKIPA Pharma Inc. (87.25M), greater than Lyra Therapeutics, Inc. (22.69M), greater than Shattuck Labs, Inc. (110.17M), greater than Vincerx Pharma, Inc. (15.98M), greater than BioAtla, Inc. (24.10M), greater than Gain Therapeutics, Inc. (10.68M), greater than TFF Pharmaceuticals, Inc. (1.89M), greater than aTyr Pharma, Inc. (138.44M), greater than IN8bio, Inc. (9.90M), greater than Lantern Pharma Inc. (24.06M), greater than Anebulo Pharmaceuticals, Inc. (41.53M), greater than Acrivon Therapeutics, Inc. Common Stock (208.47M), greater than PMV Pharmaceuticals, Inc. (40.92M), greater than Molecular Partners AG (-1929773.37), greater than Mineralys Therapeutics, Inc. (490.57M), greater than Seer, Inc. (95.89M), less than ORIC Pharmaceuticals, Inc. (633.67M), less than Cullinan Oncology, Inc. (930.13M), greater than C4 Therapeutics, Inc. (369.73M),

Build a custom stock screener for Applied Therapeutics, Inc. (APLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied Therapeutics, Inc. (APLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.